Vimarsana
Biggest News Aggregation in the World

Page 14 - Pharmacy Practice News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmacy Practice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmacy Practice Today - Breaking & Trending Today

Clinical Overview: Lecanemab Offers Hope for Patients With Alzheimer Disease - Vimarsana News

Clinical Overview: Lecanemab Offers Hope for Patients With Alzheimer Disease

Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody that targets amyloid plaques, which are thought to play a role in the development and progression of Alzheimer disease.

TEK Faculty Fellows develop courses that focus on transdisciplinary and employability skills - Vimarsana News

TEK Faculty Fellows develop courses that focus on transdisciplinary and employability skills

New TEK courses will be offered utilizing the UKC prefix during the Spring 2024 semester and will satisfy UK Core requirements. Courses focus on topics such as climate change, misinformation, creative spaces and well-being. All undergraduate students are encouraged to enroll in the new courses. 

Source: uky.edu
AI Is Revolutionizing Oncology With a Quantum Leap in Cancer Treatment - Vimarsana News

AI Is Revolutionizing Oncology With a Quantum Leap in Cancer Treatment

AI systems can detect minute anomalies often missed by the human eye, reducing false negatives.

Pharmacists have a vital role in shining a brighter light on blood cancer - Vimarsana News

Pharmacists have a vital role in shining a brighter light on blood cancer

The Pharmaceutical Journal from the Royal Pharmaceutical Society

Longest-serving University of Iowa dean to retire after 17 years - Vimarsana News

Longest-serving University of Iowa dean to retire after 17 years

University of Iowa College of Pharmacy Dean Donald E. Letendre will step down next summer -- aiming to continue leading the nationally-ranked college until his successor is hired. Even then, Letendre won’t be far -- intending to stay on faculty as a professor.